Artificial Intelligence in Early Detectionof Oral Cancer: Future of Oral Medicine

The burden of oral cancer and the need for early detection

Oral cancer continues to pose a major global health challenge, especially in developing nations. It ranks among the top ten most common cancers globally and is particularly prevalent in countries like India, Sri Lanka, Bangladesh, and Pakistan. In India alone, oral cancer accounts for approximately 30% of all cancer cases, with one of the highest incidence rates worldwide.^[2] This high burden is largely attributed to widespread use of tobacco in various forms, betel quid chewing, alcohol consumption, poor oral hygiene, and increasing exposure to oncogenic viruses such as human papillomavirus (HPV). One of the most concerning aspects of oral cancer is its typically late diagnosis. Many patients present to healthcare facilities only after the disease has progressed to an advanced stage, which significantly reduces the effectiveness of treatment and overall prognosis. The five-year survival rate for early-stage oral cancer can exceed 80%, but this figure drops to less than 30% for late-stage disease. Therefore, early detection is not just desirable; it is critical for reducing mortality, improving treatment outcomes, and enhancing the quality of life of affected individuals. Several challenges hinder early diagnosis. Early oral cancer and PMDs such as leukoplakia, erythroplakia, and oral submucous fibrosis often manifest with subtle or asymptomatic clinical features. These may be easily overlooked during routine examinations, especially in busy clinical settings or by practitioners lacking specialized training in oral medicine. In addition, socio-economic barriers, lack of awareness, limited access to healthcare, and stigma associated with cancer further delay diagnosis in vulnerable populations. The need for reliable, accessible, and non-invasive methods to detect oral cancer at an early stage has never been more pressing. Traditional diagnostic approaches, including clinical examination, biopsy, and histopathological evaluation, although considered the gold standard, are often time-consuming, invasive, and dependent on clinician expertise. Moreover, these methods may not be feasible for large-scale community-based screening programs, particularly in low-resource settings. This scenario highlights the urgent need for innovative strategies that can overcome these limitations and support early detection. AI, with its ability to analyze vast datasets, recognize complex patterns, and learn from clinical data, has the potential to fill this critical gap. By incorporating AI into routine oral health assessments, it may be possible to identify malignant transformations at a stage where intervention is most effective.^[3] This proactive approach not only helps in improving survival rates but also reduces the psychological and financial burden on patients and the healthcare system. In summary, the growing burden of oral cancer underscores the importance of early detection as a cornerstone of effective cancer control. Embracing AI-driven diagnostic tools represents a forward-thinking solution that aligns with the goals of precision medicine, early intervention, and improved public health outcomes in oral oncology.

Understanding artificial intelligence and its relevance in dentistry

AI refers to the simulation of human intelligence processes by machines, particularly computer systems. These processes include learning (the ability to acquire data and rules for using it), reasoning (using rules to reach approximate or definite conclusions), and self-correction. AI systems are designed to perform tasks that typically require human intelligence, such as visual perception, speech recognition, decision-making, and language translation.

Within AI, several subsets are particularly relevant to healthcare applications:

Machine learning (ML): A branch of AI that allows systems to automatically learn and improve from experience without being explicitly programmed.^[4] ML algorithms can analyze structured and unstructured data to recognize patterns and make predictions.

Deep learning (DL): A more advanced subset of ML, DL utilizes artificial neural networks that mimic the structure and function of the human brain. These models are especially powerful in handling large and complex datasets, such as medical images and histopathology slides.

Natural language processing (NLP): This branch of AI focuses on enabling machines to understand, interpret, and respond to human language. In healthcare, NLP can be used to analyze electronic health records (EHRs), clinical notes, and scientific literature.

Computer vision: This domain enables machines to interpret visual inputs such as photographs, radiographs, and microscopic images. It is particularly significant in fields like radiology and pathology, where visual data is central to diagnosis. In the context of dentistry and oral medicine, AI has found growing relevance across various domains, including diagnosis, treatment planning, image analysis, prognosis prediction, and patient management. Its integration into diagnostic procedures is driven by the increasing digitization of healthcare data and the need for faster, more accurate, and objective decision-makingtools.

For oral cancer and PMDs, AI can assist in several key areas:

Clinical photography analysis: AI models can analyze intraoral images to identify early changes in the mucosa, such as color variation, texture irregularities, and lesion borders that may be indicative of premalignant or malignant changes.^[5]

Radiographic interpretation: In oral radiology, AI algorithms can interpret digital radiographs, cone-beam computed tomography (CBCT), and magnetic resonance imaging (MRI) scans to detect subtle pathological changes, including bone destruction, cortical erosion, and lymph node involvement.

Histopathological and cytological evaluation: Digital pathology, when integrated with AI, enables the automatic classification of tissue architecture, nuclear pleomorphism, mitotic figures, and keratin pearl formation, all of which are critical for cancer diagnosis.

Salivary biomarker analysis: AI can assist in analyzing molecular and genomic data from salivary samples to detect biomarkers associated with early-stage oral cancer, allowing for non-invasive screening.

The relevance of AI in dentistry is further amplified by its potential in tele-dentistry, where remote diagnosis and consultation are becoming increasingly important, especially in underserved regions. AI tools can aid in triaging patients, identifying high-risk lesions, and providing decision support to general dentists and primary healthcare providers. Moreover, AI facilitates continuing education and training in Oral Medicine by offering virtual simulations, diagnostic tutorials, and automated feedback systems that help dental professionals improve their diagnostic skills.

In summary, AI is not a replacement for the clinician but a powerful tool that complements human expertise. By processing complex datasets rapidly and with high accuracy, AI can enhance clinical decision-making, reduce diagnostic errors, and pave the way for a more personalized, efficient, and equitable approach to oral healthcare. As the technology continues to evolve, its integration into routine dental practice is expected to grow, redefining standards in diagnostic excellence and patient care.

Applications of artificial intelligence in the early detection of oral cancer

AI is rapidly transforming diagnostic approaches in oral healthcare, particularly in the early detection of oral cancer and PMDs.^[6] By processing and interpreting diverse clinical, radiographic, histological, and molecular data, AI systems can help clinicians identify early pathological changes that may precede the development of OSCC. These applications span various domains of Oral Medicine and Radiology, each contributing to timely diagnosis and improved patient outcomes.

AI in image-based diagnosis of oral lesions and AI-powered systems, especially those based on CNNs, have shown significant promise in analyzing clinical photographs of oral lesions.^[7] These systems can be trained to recognize patterns associated with common PMDs such as leukoplakia, erythroplakia, lichen planus, and oral submucous fibrosis. By evaluating lesion color, texture, margin irregularity, and surface characteristics, AI models can classify lesions as benign, premalignant, or suspicious for malignancy with high sensitivity and specificity. These models are particularly useful in tele-dentistry and outreach settings where access to oral medicine specialists may be limited. A simple intraoral photograph captured via a smartphone or digital camera can be uploaded to an AI-powered platform, which rapidly screens the image and flags high-risk lesions for referral or biopsy. Example: Studies have shown that AI can achieve diagnostic accuracy comparable to experienced clinicians in distinguishing between high-risk and low-risk oral lesions using annotated image datasets.^[8]

AI in radiological interpretation andradiographic imaging plays a critical role in evaluating bone involvement, lesion extension, and lymph node metastasis in cases of oral cancer. AI algorithms are increasingly being integrated into digital radiography and CBCT analysis to assist in the detection of subtle radiographic signs of malignancy. Through DL techniques, AI can identify early bone resorption, changes in trabecular patterns, irregular cortical borders, and infiltration of adjacent structures, features that may be missed in routine visual inspection. These systems are also capable of quantifying lesion dimensions and changes over time, enabling longitudinal monitoring of lesion progression or response to therapy. Example: AI-enhanced panoramic radiographs can assist in identifying mandibular invasion by posteriorly located oral tumors, an important criterion in tumor, node, and metastasis (TNM) staging.

AI in histopathological and cytologicaldiagnoses: Histopathology remains the goldstandard for diagnosing oral cancer. However, interpretation can be subjective and time-consuming, often dependent on the expertise of pathologists. AI-based image analysis systems can digitize histopathological slides and apply automated tissue segmentation, cell classification, and morphological feature extraction to identify dysplastic and malignant changes. AI tools can objectively assess nuclear-cytoplasmic ratios, mitotic figures, cellular pleomorphism, keratin pearl formation, and invasion patterns. These quantifiable parameters enhance diagnostic consistency and reduce observer variability. In cytology, AI systems are capable of evaluating brush biopsies and exfoliative cytology slides for early atypia, providing a non-invasive and cost-effective alternative to scalpel biopsies in preliminary screenings. Example: DL algorithms have been developed that can differentiate between mild, moderate, and severe epithelial dysplasia with diagnostic accuracies exceeding 85%.

AI in saliva-based and molecular diagnostics: Saliva is increasingly being explored as a non-invasive diagnostic medium for detecting biomarkers associated with OSCC. AI can process and analyze complex salivary data, including proteomic, genomic, and metabolomic profiles, to detect molecular signatures indicative of malignancy. ML models can correlate specific patterns of gene expression, microRNAs, cytokines, or protein levels with the presence of early-stage oral cancer.^[9] These algorithms are particularly valuable for risk stratification and can be used in screening high-risk populations, such as chronic tobacco or areca nut users. Example: AI tools have been employed to interpret multiplex biomarker panels in saliva samples, achieving early detection of oral cancer even in asymptomatic individuals.

Benefits and limitations of AI in oral cancer diagnosis

The integration of AI into the diagnostic domain of oral cancer brings both exciting opportunities and practical challenges. While AI offers significant advantages in improving the accuracy, speed, and reach of early cancer detection, it is equally important to recognize and critically assess its limitations. Understanding both aspects is essential for the safe, effective, and ethical implementation of AI tools in oral healthcare practice.^[10]

Benefits of AI in oral cancer diagnosis

• Enhanced diagnostic accuracy: AI algorithms, particularly those based on DL, can process complex datasets with high precision. In image analysis, AI models can identify minute morphological changes in oral mucosa, radiographs, or histopathological slides that may not be easily visible to the human eye.^[11] This improves sensitivity and specificity, thereby reducing the likelihood of false positives and negatives

• Early detection and timely intervention: AI enables the early identification of oral PMDs and early-stage squamous cell carcinomas. Detecting these lesions before they advance can significantly improve patient prognosis, reduce treatment complexity, and enhance survival rates.

• Standardization and objectivity: Traditional diagnostics are often influenced by the clinician's experience and subjectivity.^[12] AI systems offer a standardized approach, providing consistent diagnostic results across different settings and operators, thereby minimizing inter-observer variability.

• Accessibility in remote and underserved areas: AI-powered mobile applications and cloud-based platforms allow remote screening and diagnosis through tele-dentistry.^[13] This is particularly beneficial in rural or low-resource regions where specialist access is limited, enabling broader coverage and early referral.

• Efficiency and workflow optimization: AI tools can automate repetitive and time-consuming tasks such as image labeling, report generation, and preliminary screening. This allows clinicians to focus on patient interaction and decision-making, improving overall productivity and patient throughput.

• Predictive analytics and risk stratification: ML models can analyze patient history, behavioral patterns (e.g., tobacco or alcohol use), and molecular profiles to assess cancer risk levels. Such predictive tools can guide surveillance strategies and personalized care plans.

Limitations and challenges of AI in oral cancer diagnosis

• Requirement for large, high-quality datasets: AI systems require extensive training on large and diverse datasets to function accurately. Currently, there is a lack of publicly available, well-annotated oral cancer datasets, especially from varied ethnic and geographic populations, which limits the generalizability of AI models.^[14]

• Risk of bias and overfitting: If AI models are trained on biased or limited data (e.g., data from a single population or lesion type), they may produce inaccurate or non-reproducible results when applied to new cases. This can lead to diagnostic errors or missed detections.

• Lack of clinical integration and validation: Many AI tools remain in the experimental or pilot stages and have not yet undergone rigorous clinical validation in real-world settings. The absence of standardized regulatory frameworks for AI in oral healthcare further delays clinical adoption.

• Dependence on technological infrastructure: Implementation of AI systems requires digital tools such as high-resolution imaging devices, stable internet connectivity, and data storage capabilities. These may not be readily available in underfunded public health systems or rural clinics.

• Ethical and legal concerns: Issues related to patient privacy, data security, informed consent, and medico-legal accountability are significant concerns in AI deployment. In the event of a misdiagnosis, it is unclear whether the liability lies with the clinician, the AI developer, or the institution.

• Resistance to change and lack of training: Some healthcare professionals may be hesitant to adopt AI due to unfamiliarity with the technology, fear of replacement, or skepticism about its reliability. Additionally, the current dental curriculum often lacks training in digital diagnostics or AI, creating a knowledge gap.

Future directions and recommendations

As AI continues to evolve and demonstrate potential in healthcare, its role in the early detection and management of oral cancer is expected to become increasingly prominent. However, for AI to be successfully integrated into mainstream clinical practice, a strategic roadmap is essential—one that encompasses technological advancement, clinical validation, ethical governance, and professional education.^[15] This section outlines the future directions and key recommendations for harnessing AI effectively in the field of oral oncology and oral medicine.

Development of large-scale, diverse datasets: A fundamental requirement for improving AI accuracy and reliability is the availability of large, annotated, and ethnically diverse datasets. Most current AI models in oral diagnostics are trained on limited data from single institutions or regions, which restricts their generalizability. Recommendation: Collaborative efforts between academic institutions, government health agencies, and global organizations should focus on creating centralized, anonymized data repositories. These should include a wide range of intraoral images, radiographs, histopathology slides, and genomic profiles representing varied populations and lesion types.

Clinical validation and regulatory approval: While many AI tools show promise in research settings, very few have undergone large-scale clinical validation. Without robust evidence of efficacy and safety, these technologies cannot be fully trusted or approved for routine use. Recommendation: Multi-center clinical trials should be conducted to test AI diagnostic tools in real-world settings. Regulatory bodies such as the FDA (U.S.), CDSCO (India), and CE (Europe) must establish clear guidelines and fast-track pathways for AI-based devices in dentistry.

Integration with EHRs and diagnostic platforms: For AI to be useful in daily clinical practice, it must integrate seamlessly into existing digital health infrastructure, such as EHRs, Picture Archiving and Communication Systems (PACS), and digital imaging software. Recommendation: AI developers should design interoperable systems that can be embedded into standard dental software platforms. Integration with EHRs would enable real-time decision support, lesion tracking, risk assessment, and longitudinal monitoring of patient outcomes.

Emphasis on explainable and transparent AI “Black box” AI models: They produce results without clear reasoning, limit clinician trust and accountability. There is a growing need for Explainable AI (XAI), systems that can justify their predictions and provide understandable reasoning to human users. Recommendation: Future AI models should incorporate transparency features, such as visual heatmaps or probabilistic scores, to explain how and why a particular lesion is classified as malignant or suspicious. This improves clinician confidence and facilitates collaborative diagnosis.

Ethical framework and data governance: AI applications must respect ethical standards concerning patient privacy, data protection, and informed consent. Misuse or mishandling of health data could lead to significant legal and reputational consequences. Recommendation: Develop national and institutional AI ethics policies that define who owns the data, how data can be used, and how patient confidentiality is maintained. Consent protocols must be updated to reflect AI involvement in diagnosis and risk prediction.

Education and training in AI for dental professionals: A significant barrier to AI adoption is the lack of awareness and digital literacy among dental professionals. Most undergraduate and postgraduate curricula do not include modules on AI, digital pathology, or computational diagnostics. Recommendation: Incorporate AI and digital health modules into the dental curriculum at both BDS and MDS levels. Continuing dental education (CDE) programs and workshops should be organized to upskill practicing dentists in using AI tools responsibly and effectively.

Public health applications and community screening: AI has immense potential in public health dentistry, especially for screening large populations in rural or underserved areas where specialists are scarce. AI-integrated mobile diagnostic tools can enable frontline workers to identify suspicious lesions and refer high-risk patients promptly. Recommendation: Governments and NGOs should invest in AI-based mobile screening units for early detection of oral cancer. Pilot programs can be launched in high-risk zones, with real-time data transmission to central diagnostic hubs for expert review.